etanidazole has been researched along with Oropharyngeal Neoplasms in 1 studies
Etanidazole: A nitroimidazole that sensitizes hypoxic tumor cells that are normally resistant to radiation therapy.
etanidazole : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2-nitro-1H-imidazol-1-yl)acetic acid with the amino group of ethanolamine. Used as a radiosensitising agent for hypoxic tumour cells.
Oropharyngeal Neoplasms: Tumors or cancer of the OROPHARYNX.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evans, SM | 1 |
| Du, KL | 1 |
| Chalian, AA | 1 |
| Mick, R | 1 |
| Zhang, PJ | 1 |
| Hahn, SM | 1 |
| Quon, H | 1 |
| Lustig, R | 1 |
| Weinstein, GS | 1 |
| Koch, CJ | 1 |
1 other study available for etanidazole and Oropharyngeal Neoplasms
| Article | Year |
|---|---|
Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome.
Topics: Aged; Carcinoma, Squamous Cell; Cell Hypoxia; Etanidazole; Female; Fluorescent Antibody Technique; H | 2007 |